Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM

• Status: Completed
• Trial end date: 2021-04-20
• Target enrollment: 0
• Participant gender: All

Summary

To compare the glycemic control in children with type 1 diabetes using insulin Glargine and regular insulin as basal bolus therapy versus Neutral Protamine Hagedorn insulin (NPH) and regular insulin.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Edward Medical University
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Children of age 3 to 18 years with Type 1 Diabetes Mellitus

Exclusion Criteria:

• Children below or above 18 years

• Comorbidities like celiac disease, hypothyroidism